Head and Neck Squamous Cell Carcinoma in Organ Transplant Recipients: A Single Institutional Experience

Immune suppression following solid organ transplantation with antimetabolites and other antirejection medications is a risk factor for the development of squamous cell carcinoma. While outcomes of cutaneous squamous cell cancers in organ transplant recipients (OTRs) have been reported, there is a paucity of such data in those patients who develop mucosal squamous cell carcinomas of the head and neck (HNSCC). We report the Cleveland Clinic experience with this patient population.

http://ift.tt/2Itc2NS